Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Related Posts
Delhi HC upholds Centre’s Telegram ban order ahead of NEET retest
Delhi High Court upheld the Centre’s temporary ban on Telegram, citing its potential misuse for exam fraud and misinformation ahead…
Pakistan cricket team mistaken for asylum seekers in bizarre Portsmouth mix-up
Masked protesters wrongly gathered outside a Portsmouth hotel expecting asylum seekers. They later learned the hotel housed Pakistan’s Under-19 cricket…